Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
Completed · Phase 2
Conditions studied: Liver Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining more than one chemotherapy drug may kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of gemcitabine plus docetaxel in treating patients who have unresectable or metastatic liver cancer.
Key facts
- Study ID
- NCT00006010
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 25
- Starts
- 2001-09-01
- Expected to finish
- 2008-04-01
- Last updated by the study team
- 2016-12-07
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- CCOP - Scottsdale Oncology Program — Scottsdale, Arizona, United States
- Mayo Clinic — Jacksonville, Florida, United States
- CCOP - Atlanta Regional — Atlanta, Georgia, United States
- MBCCOP - Hawaii — Honolulu, Hawaii, United States
- CCOP - Illinois Oncology Research Association — Peoria, Illinois, United States
- CCOP - Carle Cancer Center — Urbana, Illinois, United States
- CCOP - Cedar Rapids Oncology Project — Cedar Rapids, Iowa, United States
- CCOP - Iowa Oncology Research Association — Des Moines, Iowa, United States
- Siouxland Hematology-Oncology — Sioux City, Iowa, United States
- CCOP - Wichita — Wichita, Kansas, United States
- CCOP - Duluth — Duluth, Minnesota, United States
- Mayo Clinic Cancer Center — Rochester, Minnesota, United States
- Medcenter One Health System — Bismarck, North Dakota, United States
- CCOP - Toledo Community Hospital — Toledo, Ohio, United States
- CCOP - Geisinger Clinic and Medical Center — Danville, Pennsylvania, United States
- CCOP - Sioux Community Cancer Consortium — Sioux Falls, South Dakota, United States
- Allan Blair Cancer Centre — Regina, Saskatchewan, Canada
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.